Caribou Biosciences (CRBU) EBITDA Margin Growth (1y) (2021 - 2026)
Caribou Biosciences (CRBU) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Caribou Biosciences |
156.73 Mn |
39.11 Mn |
- |
65,154.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
65,154.00 |
| Dec 31, 2025 |
106,256.00 |
| Sep 30, 2025 |
40,798.00 |
| Jun 30, 2025 |
-94,502.00 |
| Mar 31, 2025 |
875.00 |
| Dec 31, 2024 |
-79,305.00 |
| Sep 30, 2024 |
-161,728.00 |
| Jun 30, 2024 |
-29,123.00 |
| Mar 31, 2024 |
-93,376.00 |
| Dec 31, 2023 |
-22,436.00 |
| Sep 30, 2023 |
77,888.00 |
| Jun 30, 2023 |
-14,834.00 |
| Mar 31, 2023 |
-2,597.00 |
| Dec 31, 2022 |
1,038.00 |
| Sep 30, 2022 |
-29,311.00 |
| Jun 30, 2022 |
32,099.00 |
| Mar 31, 2022 |
7,737.00 |
| Dec 31, 2021 |
81,844.00 |
| Sep 30, 2021 |
15,951.00 |
| Jun 30, 2021 |
-94,298.00 |
